|
Brooke MastersFinancial Times |
The Trump administration’s looser rules could breed more ‘cockroaches’ in the lending market

These disclosures are no passing regulatory fad but a bedrock of US markets

GLP-1 medications could be the group’s death knell — or grant it a new lease on life

As AI bites and job cuts surge, employees are losing ground — for now

Trump’s pressure on food and drink manufacturing raises questions of fairness and predictability

The athleisure group is challenging public enthusiasm for ‘dupe’ products

Reducing disclosure of C-suite packages under the guise of cutting red tape carries risks

Some worry that PE funds could become a dumping ground

The dairy industry’s efforts to woo customers away from plant products are a masterclass in corporate survival tactics

The failure of business to join universities in the fight for academic research is short-sighted as well as cowardly

A range of policies, including tariffs, are leading foreign firms to question their dependence on US funding

As conservatives find judicial allies, companies should expect more challenges

Managing smooth updates is becoming ever important with the spread of EVs and more sophisticated systems

The asset manager’s acquisition tear makes the leadership succession process more complex

Companies should take advantage of opportunities created by improved technology and changing tastes

Retail banking is not only harder than it looks but also heavily regulated by watchdogs who take their duties very seriously

Governments and business are trying to work out who to blame for cheapflation

Weight-loss drugs and a new focus on wellness are pushing many exercise machines towards obsolescence

Airline loyalty programmes have tested customer patience and now face government probes

Customers are growing more resentful as gratuities soar

The certificates trace reduction instead of offsetting it with unconnected activity like planting trees
